Tango Therapeutics, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-27 | NCT07897734 TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of… | Phase 1/2 | Not Yet Recruiting |
Active trials by phase
| Phase 1/2 | 5 |
Disease areas by active trials
Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (4) · Pancreatic Cancer (2) · Cholangiocarcinoma (1) · Glioblastoma (1) · Glioma (1) · Mesothelioma (1) · Sarcoma (1)
Get alerts when Tango Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.